Overview

The Clinical Efficacy of DFPP in Patients With AAGN

Status:
Terminated
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The clinical efficacy of double filtration plasmapheresis(DFPP) in patients with antineutrophil cytoplasmic autoantibody associated glomerulonephritis(AAGN).
Phase:
N/A
Details
Lead Sponsor:
Zhi-Hong Liu, M.D.
Treatments:
Cyclophosphamide
Methylprednisolone